Skip to main content
. Author manuscript; available in PMC: 2016 Jan 22.
Published in final edited form as: Neuroscience. 2014 Nov 5;0:719–729. doi: 10.1016/j.neuroscience.2014.10.061

Fig. 5.

Fig. 5

Progressive reduction of DPOAE in Cx26 cKO mice. The mice were injected with 4-HTMX at P10. WT littermates served as controls. a: Spectrum of acoustic emission recorded from Cx26 cKO mice and WT mice. Insets: Large scale plotting of 2f1-f2 and f1 peaks. The peak of DPOAE (2f1-f2) in Cx26 cKO mice was reduced but f1 and f2 peaks remained the same as those in WT mice. f0=20 kHz. b: Reduction of DPOAE in Cx26 cKO mice in I/O plot. Dashed lines represent the noise levels of recording. c: Progressive reduction of DPOAE in Cx26 cKO mice. d: Large reduction of DPOAE at high-frequencies in Cx26 cKO mice. *: P<0.05, **: P < 0.001 as determined by one-way ANOVA with a Bonferroni correction.